Vote Scores

Home / Companies / 89bio, Inc.

Company · votes reported on Form N-PXname as filed

89bio, Inc.

How funds and institutional managers reported voting their shares, year to 30 June 2025

Filers reporting
264year to 30 June 2025
Against management on pay
29.0%74 of 255 reporting filers
Same, by reported shares
6.1%shares reported on Form N-PX
Meetings on file
2across 2 seasons
68.2% for28.0% against3.8% other29.0% against management264 filers on say-on-pay

foragainstabstain, withhold or otheramber tick: the portion cast against management

For the year to 30 June 2025, 264 funds and managers listed 89bio, Inc. in their Form N-PX filings (one meeting).

On the advisory vote on executive pay, 74 of the 255 filers that reported a position voted against management (29.0%), 20.9 percentage points above the median company on this site (8.1%). By reported shares the figure is 6.1% (median 4.0%). These are shares of the filers reporting on Form N-PX, not of all votes cast at the meeting.

Among the largest fund families, 30 voted with management on pay and 10 voted against: PGIM and Prudential, Dimensional, American Century, Invesco, SEI, Global X, Neuberger Berman and Natixis and Loomis Sayles and others.

Meetings

Meeting dateSeasonFilers reportingItemsAgainst management on pay
28 May 2025year to 30 June 2025264329.0%
29 May 2024year to 30 June 202422746.5%

Meetings with 20 or more reporting filers have their own page with every item. Dates are as filers typed them; dates up to three days apart are treated as one meeting.

Say-on-pay: this company and the median

year to 30 June 202589bio, Inc.Median company
Reporting filers voting against management29.0%8.1%
Reported shares voted against management6.1%4.0%

Among filers reporting on Form N-PX. The median is over 3,794 companies with a say-on-pay item reported by 20 or more filers.

How the largest families voted

Meeting of 28 May 2025: say-on-pay and each shareholder proposal that could be told apart.

FamilySay-on-pay
VanguardFor
BlackRock and iSharesFor
FidelityFor
DimensionalAgainst *
State Street and SPDRFor
American CenturyAgainst *
Franklin TempletonFor
InvescoAgainst *
EquitableFor
Charles SchwabFor
Nuveen and TIAAFor
ProShares and ProFundsFor
John Hancock and ManulifeFor
Morgan Stanley, Eaton Vance and CalvertFor
J.P. MorganFor
Goldman SachsFor
PGIM and PrudentialAgainst *
Jackson National fundsAgainst *
Northern Trust and FlexSharesFor
SEIAgainst *
T. Rowe PriceFor
Lincoln FinancialFor
VoyaFor
First TrustFor
NationwideFor
Victory CapitalFor
Brighthouse FundsFor
Guggenheim and RydexFor
BNY MellonFor
PrincipalFor
Pacific Life fundsFor
Global XAgainst *
Federated HermesAgainst *
AllianceBernsteinFor
DWSFor
Harbor FundsFor
Janus HendersonFor
Neuberger BermanAgainst *
Natixis and Loomis SaylesAgainst *
Lord AbbettFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

By season

SeasonFilers reportingAgainst management on pay, filersBy reported sharesSay-on-pay split
year to 30 June 20242286.5%1.5%
year to 30 June 202526429.0%6.1%

Category mix

Share of the vote records reported for this company, by the category filers chose.

CategoryVote recordsShare
SECTION 14A SAY-ON-PAY VOTES1,00647.1%
DIRECTOR ELECTIONS84939.7%
AUDIT-RELATED28313.2%

Questions

How did large funds vote at 89bio, Inc.?

For the year to 30 June 2025, 255 Form N-PX filers reported a say-on-pay vote at 89bio, Inc.; 74 voted against management (29.0%). The table on this page lists the position of each of the largest fund families on say-on-pay and on each shareholder proposal that could be told apart in the filings.

Were there shareholder proposals at 89bio, Inc.?

No proposal from security holders was reported by enough filers to be shown for the year to 30 June 2025.

Is this the meeting result?

No. The figures are shares of the funds and managers that file Form N-PX, and of the shares they reported. Holders that do not file the form (individuals, most foreign investors, insiders) are not included, so the split here can differ widely from the certified result, which 89bio, Inc. reports on Form 8-K.

Where does the data come from?

From Form N-PX filings on the SEC's EDGAR system, grouped by company. Filers type company names and meeting dates themselves; this site groups spellings of the same company and folds meeting dates up to three days apart. Data runs through 30 Sep 2026; the median compares 3,794 companies.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list 89bio, Inc., grouped by company. The name is the most common spelling among filers. Not verified by the SEC. Filings read through 30 Sep 2026; page built 1 Oct 2026.